Literature DB >> 22438425

Does imaging-guided selection of patients with ischemic heart failure for high risk revascularization improve identification of those with the highest clinical benefit?: Myocardial imaging should not exclude patients with ischemic heart failure from coronary revascularization.

Eric J Velazquez1.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22438425      PMCID： PMC3878903          DOI： 10.1161/CIRCIMAGING.111.964650

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN： 1941-9651            Impact factor:   7.792


× No keyword cloud information.
  56 in total

1.  Revascularization in patients with coronary artery disease, left ventricular dysfunction, and viability: a meta-analysis.

Authors:  Jamieson Macdonald Bourque; Vic Hasselblad; Eric J Velazquez; Salvador Borges-Neto; Christopher M O'connor
Journal:  Am Heart J       Date:  2003-10       Impact factor: 4.749

Review 2.  Lessons learned from recent cardiovascular clinical trials: Part I.

Authors:  David L DeMets; Robert M Califf
Journal:  Circulation       Date:  2002-08-06       Impact factor: 29.690

3.  Acute heart failure complicating acute coronary syndromes: a deadly intersection.

Authors:  Eric J Velazquez; Marc A Pfeffer
Journal:  Circulation       Date:  2004-02-03       Impact factor: 29.690

4.  A decade of change--risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons.

Authors:  T Bruce Ferguson; Bradley G Hammill; Eric D Peterson; Elizabeth R DeLong; Frederick L Grover
Journal:  Ann Thorac Surg       Date:  2002-02       Impact factor: 4.330

5.  Serial changes on quantitative myocardial perfusion SPECT in patients undergoing revascularization or conservative therapy.

Authors:  D S Berman; X Kang; E F Schisterman; J Gerlach; P B Kavanagh; J S Areeda; T Sharir; S W Hayes; L J Shaw; H C Lewin; J D Friedman; R Miranda; G Germano
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

6.  Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis.

Authors:  Kevin C Allman; Leslee J Shaw; Rory Hachamovitch; James E Udelson
Journal:  J Am Coll Cardiol       Date:  2002-04-03       Impact factor: 24.094

7.  Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy.

Authors:  David Bello; Dipan J Shah; George M Farah; Silvia Di Luzio; Michele Parker; Maryl R Johnson; William G Cotts; Francis J Klocke; Robert O Bonow; Robert M Judd; Mihai Gheorghiade; Raymond J Kim
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

8.  Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON).

Authors:  Jay N Cohn; Marc A Pfeffer; Jean Rouleau; Norman Sharpe; Karl Swedberg; Matthias Straub; Curtis Wiltse; Theressa J Wright
Journal:  Eur J Heart Fail       Date:  2003-10       Impact factor: 15.534

9.  Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

Authors:  Douglas L Mann; John J V McMurray; Milton Packer; Karl Swedberg; Jeffrey S Borer; Wilson S Colucci; Jacques Djian; Helmut Drexler; Arthur Feldman; Lars Kober; Henry Krum; Peter Liu; Markku Nieminen; Luigi Tavazzi; Dirk Jan van Veldhuisen; Anders Waldenstrom; Marshelle Warren; Arne Westheim; Faiez Zannad; Thomas Fleming
Journal:  Circulation       Date:  2004-03-15       Impact factor: 29.690

10.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690
View more
  3 in total

1.  The feasibility of myocardial infarct visualization using atrial kick induced strain (AKIS) contrast.

Authors:  Brett Byram; Han Kim; Lowie Van Assche; Patrick D Wolf; Gregg E Trahey
Journal:  Ultrasound Med Biol       Date:  2014-03-07       Impact factor: 2.998

2.  Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction.

Authors:  Julio A Panza; Thomas A Holly; Federico M Asch; Lilin She; Patricia A Pellikka; Eric J Velazquez; Kerry L Lee; Salvador Borges-Neto; Pedro S Farsky; Robert H Jones; Daniel S Berman; Robert O Bonow
Journal:  J Am Coll Cardiol       Date:  2013-03-07       Impact factor: 24.094

3.  Molecular In Vivo Imaging Using a Noninvasive Cardiac-Specific MLC-2v Promoter Driven Dual-Gene Recombinant Lentivirus Monitoring System.

Authors:  Miao Zhang; Lihua Wang; Rui Guo; Sheng Liang; Xufeng Jiang; Min Zhang; Biao Li
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.